Published: Thu, February 15, 2018
Finance | By Loren Pratt

AbbVie Inc (ABBV) Shares Sold by California State Teachers Retirement System


Hudock Capital Group LLC now owns 1,542 shares of the company's stock worth $111,000 after buying an additional 806 shares during the last quarter. The institutional investor held 59,818 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.32 million, up from 51,408 at the end of the previous reported quarter. Choate Investment Advisors who had been investing in Blackrock Inc Cl A for a number of months, seems to be bullish on the $84.13 billion market cap company. Insiders sold 450,743 shares of company stock worth $43,153,684 in the last quarter. About 2.63M shares traded.

California State Teachers Retirement System lowered its position in AbbVie Inc (NYSE:ABBV) by 8.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). It has underperformed by 4.51% the S&P500.

Reynders Mcveigh Capital Management Llc increased its stake in Danaher Corp (DHR) by 8.22% based on its latest 2017Q3 regulatory filing with the SEC. The fund owned 305,089 shares of the company's stock after selling 103,064 shares during the quarter. The institutional investor held 177,931 shares of the railroads company at the end of 2017Q3, valued at $9.66 million, down from 184,902 at the end of the previous reported quarter. The Weekly Volatility is 4.32% and the Monthly Volatility is 2.81%. About 3.50 million shares traded. Danaher Corporation (NYSE:DHR) has risen 10.62% since February 12, 2017 and is uptrending. It has outperformed by 48.70% the S&P500. Following the completion of the sale, the senior vice president now owns 113,118 shares of the company's stock, valued at approximately $11,136,467.10.

As regular trading ended, AbbVie Inc. The stock has a consensus rating of "Buy" and an average target price of $86.66. Bank of America upgraded International Paper Company (NYSE:IP) on Tuesday, January 2 to "Buy" rating. RBC Capital Markets maintained the stock with "Buy" rating in Wednesday, July 19 report. (NYSE:ABBV) earned "Buy" rating by Piper Jaffray on Thursday, September 28. (NYSE:ABBV) was sold by RICHMOND TIMOTHY J. on Monday, December 18. On Thursday, January 4 the stock rating was maintained by Jefferies with "Buy". However, most people believe that a higher stock price indicates a larger company where the price might also be misread as the definite worth of a company.


Investors sentiment decreased to 0.85 in 2017 Q3. Its up 0.17, from 1.45 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings.

A number of hedge funds have recently added to or reduced their stakes in the stock. Rothschild Asset Inc invested in 3.01 million shares or 1.3% of the stock. Vanguard Grp Inc Inc holds 117.95 million shares. Baystate Wealth Limited Liability Company invested 0.06% of its portfolio in AbbVie Inc. (NYSE:ABBV) is performing, let's look at some of the company's recent insider trading activity. Nationwide Fund Advsrs stated it has 0.18% of its portfolio in AbbVie Inc. (NYSE:ABBV) or 1.39 million shares. Numeric Ltd Liability Company has 458,500 shares for 0.31% of their portfolio. Hillswick Asset Mgmt Limited Com accumulated 85,352 shares or 2.45% of the stock. Great Lakes Advsr Ltd Com has invested 0.96% in AbbVie Inc. 511.08 million shares or 0.43% more from 508.92 million shares in 2017Q2 were reported. Hershey Trust Co. purchased a new position in shares of AbbVie in the third quarter worth $139,000. Palisade Asset Management LLC grew its holdings in shares of AbbVie by 17.9% during the second quarter. Nikko Asset Management Americas holds 0.03% of its portfolio in AbbVie Inc.

In other news, Chairman Richard A. Gonzalez sold 218,193 shares of the firm's stock in a transaction on Tuesday, November 21st. On Monday, September 11 the insider SALEKI-GERHARDT AZITA sold $705,655. (NYSE:ABBV) or 140,371 shares. The forecast of 4 surveyed investment analysts covering the stock advises investors to Buy stake in the company. Therefore 44% are positive. General Electric Company had 88 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has "Hold" rating given on Wednesday, October 11 by BMO Capital Markets. (NYSE:T) earned "Outperform" rating by Oppenheimer on Saturday, September 5. The firm earned "Buy" rating on Monday, December 18 by Credit Suisse. The stock has "Neutral" rating by DA Davidson on Friday, February 3. The stock is a Buy among 6 brokerage firms polled by Factset Research. The rating was downgraded by JP Morgan to "Neutral" on Thursday, September 8. Barclays Capital maintained it with "Overweight" rating and $50 target in Monday, January 30 report. Sit Investment Assoc Inc has invested 0.95% in AbbVie Inc. Indiana Tru Mngmt invested in 0.92% or 78,898 shares. 65 funds opened positions while 204 raised stakes. It worsened, as 112 investors sold GE shares while 818 reduced holdings. Lau Assoc Limited Co stated it has 13,079 shares.

Donaldson Capital Management Llc, which manages about $967.55 million and $952.70 million US Long portfolio, upped its stake in Maxim Integrated Products (NASDAQ:MXIM) by 26,821 shares to 444,732 shares, valued at $21.22 million in 2017Q3, according to the filing. The Lpl Financial Llc holds 552,268 shares with $49.08 million value, down from 600,033 last quarter. Cleararc Cap has invested 0.19% in CSX Corporation (NASDAQ:CSX). Clifford Swan Inv Counsel Limited has invested 0.93% in AbbVie Inc. Strategic Svcs owns 23,402 shares. Virtu Ltd Liability has invested 0% in General Electric Company (NYSE:GE).

Like this: